Blueprint Medicines Corporation (LON:0HOJ)
84.70
+0.44 (0.52%)
At close: Apr 23, 2025
Blueprint Medicines Employees
Blueprint Medicines had 649 employees as of December 31, 2024. The number of employees decreased by 6 or -0.92% compared to the previous year.
Employees
649
Change (1Y)
-6
Growth (1Y)
-0.92%
Revenue / Employee
626.25K GBP
Profits / Employee
-82.57K GBP
Market Cap
4.13B
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
AstraZeneca | 94,300 |
GSK plc | 68,629 |
Haleon | 24,561 |
Smith & Nephew | 17,349 |
ConvaTec Group | 10,489 |
Hikma Pharmaceuticals | 9,500 |
HUTCHMED (China) | 1,811 |
Oxford Nanopore Technologies | 1,315 |
Blueprint Medicines News
- 17 days ago - Blueprint Medicines Continues Targeting Mast Cells For Potential Billion-Dollar Growth - Seeking Alpha
- 24 days ago - Blueprint Medicines to Present at 24th Annual Needham Virtual Healthcare Conference - PRNewsWire
- 26 days ago - Blueprint Medicines: Strong Business, Ambitious Targets, Expensive Stock - Seeking Alpha
- 5 weeks ago - This Blueprint Medicines Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday - Benzinga
- 7 weeks ago - Blueprint Medicines Highlights Leading Portfolio of Mast Cell-Targeted Therapies at 2025 AAAAI / WAO Joint Congress - PRNewsWire
- 2 months ago - Blueprint Medicines projects $680M-$710M AYVAKIT revenue in 2025 with 45% growth - Seeking Alpha
- 2 months ago - Blueprint Medicines Corporation 2024 Q4 - Results - Earnings Call Presentation - Seeking Alpha
- 2 months ago - Blueprint Medicines Corporation (BPMC) Q4 2024 Earnings Call Transcript - Seeking Alpha